# Neurotoxicity Prophylaxis With Intrathecal Dexamethasone and Simvastatin Post Axi-Cel

> **NCT04514029** · EARLY_PHASE1 · ACTIVE_NOT_RECRUITING · sponsor: **Masonic Cancer Center, University of Minnesota** · enrollment: 37 (actual)

## Conditions studied

- Lymphoma

## Interventions

- **DRUG:** Simvastatin
- **DRUG:** Dexamethasone

## Key facts

- **NCT ID:** NCT04514029
- **Lead sponsor:** Masonic Cancer Center, University of Minnesota
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2020-08-06
- **Primary completion:** 2023-11-03
- **Final completion:** 2026-12
- **Target enrollment:** 37 (ACTUAL)
- **Last updated:** 2026-01-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04514029

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04514029, "Neurotoxicity Prophylaxis With Intrathecal Dexamethasone and Simvastatin Post Axi-Cel". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT04514029. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*